Artificial intelligence startup IO Health Technologies has secured $2 million in seed funding, led by investment firm Nina Capital. This financial boost will enable IO Health to expand its AI-driven quality management platform for home health and hospice providers. According to CEO Dr. David Bell, the platform focuses on improving documentation accuracy, which in turn reduces administrative workload, accelerates billing, and enhances clinician satisfaction. Accurate documentation is linked to significantly better clinical and financial outcomes compared to efficiency improvements alone.
With workforce shortages affecting the hospice sector, many providers are turning to AI to ease the burden of clinical documentation. A 2023 survey by The Amity Group revealed that hospice nurses rank documentation as their top job concern, with over 90% reporting they complete these tasks at home outside of work hours.
Founded in 2023 in California by home health industry veterans, IO Health has developed a suite of patent-pending tools to expedite and enhance clinical documentation. The recent funding will support the expansion of their Optimized solution, which includes three applications: ioAssist, ioIQ, and ioDoc. These tools offer real-time validation, streamline review processes, and automate patient documentation.
Marc Subirats, Nina Capital’s General Partner and former CEO of Advance Medical, will join IO Health’s Board of Directors. His experience in scaling healthcare ventures is expected to be invaluable as IO Health grows.
